NAD+ Research: What Published Studies Have Investigated

What is NAD+?

What is NAD+? Nicotinamide adenine dinucleotide is a dinucleotide coenzyme present in every living cell and central to energy metabolism (Cantó, Menzies & Auwerx, 2015). It is one of the most fundamental cofactors in biochemistry, and this page summarises what the literature describes about it — not outcomes.

Is NAD+ a peptide?

No. This is worth answering directly because Cellworks catalogues NAD+ alongside research peptides: NAD+ is a dinucleotide — two nucleotides, one built on nicotinamide and one on adenine, joined by phosphate bridges — which makes it a coenzyme/cofactor, not a chain of amino acids. Correcting that chemistry up front matters, because much of the vendor content around NAD+ blurs it with the peptides it is stocked beside.

Molecule and coenzyme properties

Structurally, NAD+ links an adenine nucleotide and a nicotinamide nucleotide through ribose sugars and a pyrophosphate bridge; the nicotinamide ring is the redox-active site. The molecule exists in an oxidised state (NAD+) and a reduced state (NADH). In laboratory settings it is typically handled as a free acid or disodium salt in lyophilized powder form. These are molecule facts only.

NAD+ mechanisms researchers have examined

The literature characterises two broad functional roles for NAD+, each framed as what studies describe:

Redox cofactor

NAD+ accepts a hydride (H−, two electrons plus one proton) at the nicotinamide ring to become NADH. This NAD+/NADH couple carries reducing equivalents through glycolysis and the citric acid cycle to Complex I of the electron transport chain (Biochemistry, Electron Transport Chain, StatPearls/NCBI Bookshelf). The distinction between NAD+ and NADH is exactly this: they are the two states of one redox couple, oxidised and reduced.

Substrate for signalling enzymes (sirtuins, PARPs, CD38)

Beyond its redox role, NAD+ is consumed as a substrate by several classes of enzyme: sirtuins (NAD+-dependent deacylases), PARPs (in the DNA-damage response) and CD38 (an NADase). These enzymes cleave NAD+ and release nicotinamide (Covarrubias, Perrone, Grozio & Verdin, 2021). This substrate role is why NAD+ metabolism is studied in signalling contexts and not only in bioenergetics.

NAD+ vs its precursors (NMN, NR)

A common confusion is worth clarifying: much research uses NAD+ precursors — nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) — rather than NAD+ itself, largely because of cellular-uptake considerations. Reduced precursor forms (NMNH, NRH) are also being characterised (a 2025 hepatocyte study comparing reduced vs oxidised precursors, PMC12911941; Yang et al., 2025, a Food Frontiers NMN/NR review). Stated neutrally, this describes what is under study; it makes no potency or benefit comparison between NAD+ and its precursors.

Research models and the aging-metabolism literature

What the literature investigates includes NAD+ metabolism in energy homeostasis, mitochondrial function, and sirtuin activity. The reported age-associated NAD+ decline is a hypothesis under active debate: some work associates aging with lower NAD+ and with CD38-driven consumption (Imai & Guarente, 2016; Chini group, 2020), while other work argues that measured declines are tissue-specific and contested (McReynolds, Chellappa & Baur, 2021, “Age-Dependent Decline of NAD+ — Universal Truth or Confounded Consensus?”). The honest framing is that this is preclinical and mechanistic biology under study — findings about biology, not human outcomes.

What a research-grade NAD+ solution looks like

Appearance and stability are allowed, descriptive facts. NAD+ powder is typically white to off-white, and freshly reconstituted aqueous NAD+ is normally clear and pale — a deepening amber/yellow-brown colour or cloudiness can indicate degradation. NAD+ undergoes base-catalysed degradation and is temperature-labile in solution (Long-Term Stability of Nicotinamide Cofactors in Common Aqueous Buffers, PMC11597533 / NREL, 2024); it is generally kept cold and protected from light, and degrades faster at room temperature. This is a description of appearance and stability, not a handling-for-use instruction. For the broader “what real research material looks like” appearance-and-verification companion, a sibling trust article accompanies this series.

NAD+ research material and why these are not supplements

A large share of the questions that reach this page arrive phrased as “NAD supplement” or “NAD+ supplement,” so the distinction is worth stating plainly rather than leaving to inference. A supplement is a consumer product formulated, labelled and regulated to be taken by a person. What is described on this page — and what Cellworks supplies — is laboratory research material: a defined compound characterised by identity and purity, intended for in-vitro and laboratory work only. The two are different categories of thing, not two grades of the same thing.

Three consequences follow, and each is a factual statement rather than a caution attached for form’s sake:

• Different regulatory category — supplements are regulated as food or consumer products in most jurisdictions and carry labelling built around human intake. Research material is not a drug, food, cosmetic or medical device, and carries no intake labelling because it is not for intake.
• Different documentation — a supplement label carries a serving size. A research batch carries a Certificate of Analysis: measured HPLC purity, mass-spec identity confirmation, and a lot number that ties the paperwork to the vial in front of you. That certificate answers “what is this and how pure is it,” which is the only question a research buyer can actually verify.
• Different literature — most of the NAD+ research summarised above sits in cell and animal models, and much of it uses precursors rather than NAD+ itself. It describes biology under study. It is not evidence for a consumer product, and nothing on this page should be read as a use, a benefit or an outcome.

So the honest answer to “is this an NAD supplement?” is no — and the reason is not a technicality. Calling research material a supplement would imply a human-intake use that neither the material, the paperwork, nor the published literature supports.

Research-grade sourcing & verification

For laboratory research use only, NAD+ is supplied with a per-batch Certificate of Analysis reporting HPLC purity (%) and mass-spec identity confirmation, with third-party verification. Check the exact batch on the self-serve verify tool, and see how to read a COA for what the certificate reports.

NAD+ is listed with the rest of our peptides catalogue, even though it is a coenzyme rather than a peptide.

Frequently asked questions

Literature cited

1. Cantó C, Menzies KJ, Auwerx J. “NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus.” Cell Metabolism. 2015 (PMC4487780).
2. Covarrubias AJ, Perrone R, Grozio A, Verdin E. “NAD+ metabolism and its roles in cellular processes during ageing.” Nature Reviews Molecular Cell Biology. 2021.
3. Imai S, Guarente L. “It takes two to tango: NAD+ and sirtuins in aging/longevity control.” npj Aging and Mechanisms of Disease. 2016 (PMID 28721271).
4. Chini CCS, et al. “CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels.” Nature Metabolism. 2020.
5. McReynolds MR, Chellappa K, Baur JA. “Age-Dependent Decline of NAD+ — Universal Truth or Confounded Consensus?” Nutrients. 2021 (PMC8747183).
6. Yang Y, et al. “An Updated Review on the Mechanisms, Pre-Clinical and Clinical Comparisons of NMN and NR.” Food Frontiers. 2025.
7. “Reduced Versus Oxidized NAD+ Precursors Drive Distinct Transcriptomic, Proteomic, and Metabolic Profiles in Hepatocytes.” 2025 (PMC12911941).
8. “Long-Term Stability of Nicotinamide Cofactors in Common Aqueous Buffers.” 2024 (PMC11597533 / NREL).
9. Biochemistry, Electron Transport Chain. StatPearls / NCBI Bookshelf, NBK526105 (redox / hydride-transfer background).